Results
|
1.
|
First-in-Man Dose-Escalation Study of the Selective BRAF Inhibitor RG7256 in Patients with BRAF V600-Mutated Advanced Solid Tumors. [electronic resource] by
- Dienstmann, Rodrigo
- Lassen, Ulrik
- Cebon, Jonathan
- Desai, Jayesh
- Brown, Michael P
- Evers, Stefan
- Su, Fei
- Zhang, Weijiang
- Boisserie, Frederic
- Lestini, Brian
- Schostack, Kathleen
- Meresse, Valerie
- Tabernero, Josep
Producer: 20170227
In:
Targeted oncology vol. 11
Availability: No items available.
|
|
2.
|
Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer. [electronic resource] by
- Yang, Hong
- Higgins, Brian
- Kolinsky, Kenneth
- Packman, Kathryn
- Bradley, William D
- Lee, Richard J
- Schostack, Kathleen
- Simcox, Mary Ellen
- Kopetz, Scott
- Heimbrook, David
- Lestini, Brian
- Bollag, Gideon
- Su, Fei
Producer: 20120330
In:
Cancer research vol. 72
Availability: No items available.
|
|
3.
|
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models. [electronic resource] by
- Yang, Hong
- Higgins, Brian
- Kolinsky, Kenneth
- Packman, Kathryn
- Go, Zenaida
- Iyer, Raman
- Kolis, Stanley
- Zhao, Sylvia
- Lee, Richard
- Grippo, Joseph F
- Schostack, Kathleen
- Simcox, Mary Ellen
- Heimbrook, David
- Bollag, Gideon
- Su, Fei
Producer: 20100809
In:
Cancer research vol. 70
Availability: No items available.
|
|
4.
|
RG7212 anti-TWEAK mAb inhibits tumor growth through inhibition of tumor cell proliferation and survival signaling and by enhancing the host antitumor immune response. [electronic resource] by
- Yin, Xuefeng
- Luistro, Leopoldo
- Zhong, Hua
- Smith, Melissa
- Nevins, Tom
- Schostack, Kathleen
- Hilton, Holly
- Lin, Tai-An
- Truitt, Theresa
- Biondi, Denise
- Wang, Xiaoqian
- Packman, Kathryn
- Rosinski, Jim
- Berkofsky-Fessler, Windy
- Tang, Jian-Ping
- Pant, Saumya
- Geho, David
- Vega-Harring, Suzana
- Demario, Mark
- Levitsky, Hy
- Simcox, Mary
Producer: 20140519
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
5.
|
Resistance to selective BRAF inhibition can be mediated by modest upstream pathway activation. [electronic resource] by
- Su, Fei
- Bradley, William D
- Wang, Qiongqing
- Yang, Hong
- Xu, Lizhong
- Higgins, Brian
- Kolinsky, Kenneth
- Packman, Kathryn
- Kim, Min Jung
- Trunzer, Kerstin
- Lee, Richard J
- Schostack, Kathleen
- Carter, Jade
- Albert, Thomas
- Germer, Soren
- Rosinski, Jim
- Martin, Mitchell
- Simcox, Mary Ellen
- Lestini, Brian
- Heimbrook, David
- Bollag, Gideon
Producer: 20120420
In:
Cancer research vol. 72
Availability: No items available.
|
|
6.
|
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers. [electronic resource] by
- Lassen, Ulrik N
- Meulendijks, Didier
- Siu, Lilian L
- Karanikas, Vaios
- Mau-Sorensen, Morten
- Schellens, Jan H M
- Jonker, Derek J
- Hansen, Aaron R
- Simcox, Mary E
- Schostack, Kathleen J
- Bottino, Dean
- Zhong, Hua
- Roessler, Markus
- Vega-Harring, Suzana M
- Jarutat, Tiantom
- Geho, David
- Wang, Ka
- DeMario, Mark
- Goss, Glenwood D
Producer: 20150917
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 21
Availability: No items available.
|
|
7.
|
Exposure and Tumor Fn14 Expression as Determinants of Pharmacodynamics of the Anti-TWEAK Monoclonal Antibody RG7212 in Patients with Fn14-Positive Solid Tumors. [electronic resource] by
- Meulendijks, Didier
- Lassen, Ulrik N
- Siu, Lillian L
- Huitema, Alwin D R
- Karanikas, Vaios
- Mau-Sorensen, Morten
- Jonker, Derek J
- Hansen, Aaron R
- Simcox, Mary E
- Schostack, Kathleen J
- Bottino, Dean
- Zhong, Hua
- Roessler, Markus
- Vega-Harring, Suzana M
- Jarutat, Tiantom
- Geho, David
- Wang, Karen
- DeMario, Mark
- Goss, Glenwood D
- Schellens, Jan H M
Producer: 20161103
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 22
Availability: No items available.
|